One of the key biomarkers which was explored in many studies was NT-ProBNP with Zhang et al., Castelvecchio et al. and Van Boven exploring its association with adverse events in a chronic heart failure population [28, 36, 44]. This evidence concerns the gene NPPB and congestive heart failure.